Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2023 Earnings Call Transcript
Marinus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.74 EPS, expectations were $-0.64. Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals Inc. (MRNS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 5,108,520 | $46,181,021 | -5% | 1.71% |
| 2. | VenBio Select Advisor Kurt Von Emster | 4,140,607 | $37,431,087 | +32% | 0.43% |
| 3. | Cormorant Asset Management Bihua Chen | 3,250,000 | $29,380,000 | 1.28% | |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 2,331,250 | $21,074,500 | -10% | 0.03% |
| 5. | Lion Point Didric Cederholm | 2,119,136 | $19,156,989 | -1% | 10.7% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.25 | 100,000 | Officer, Director | 100,000 | 2019-12-13 | Filing | |
| $5.61 | 3,561 | Officer, Director | 116,085 | 2015-11-06 | Filing | |
| $8.00 | 419,744 | Large Shareholder | 2,476,886 | 2014-08-05 | Filing | |
| $8.00 | 12,528 | Large Shareholder, Director | 27,998 | 2014-08-05 | Filing | |
| $8.00 | 13,367 | Large Shareholder, Director | 238,212 | 2014-08-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.56 | 2,153 | 60,308 | 2024-02-20 | Filing | ||
| $9.57 | 1,894 | 52,966 | 2024-02-20 | Filing | ||
| $9.98 | 2,814 | 66,635 | 2024-02-16 | Filing | ||
| $9.97 | 3,092 | 71,697 | 2024-02-16 | Filing | ||
| $9.94 | 11,850 | 223,512 | 2024-02-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,599,278 | $49,994,152 | 0% | |
| 2. | 4,529,997 | $49,241,067 | 0.8% | |
| 3. | 3,833,955 | $41,675,091 | 0.01% | |
| 4. | 2,959,161 | $32,166,081 | 0.02% | |
| 5. | 2,673,231 | $29,058,021 | 0% |
News See All
5 Hyper-Growth Stocks Billionaires Are Loading Up On
This article presents an overview of the 5 Hyper-Growth Stocks Billionaires Are Loading Up On. For a detailed overview of such stocks, read our article, 11 Hyper-Growth Stocks Billionaires Are Loading...
5 Most Promising Long-Term Stocks According to Analysts
In this piece, we will take a look at the five most promising long-term stocks according to analysts.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals' Third Quarter 2023 Financial Results and Business Update Call. [Operator Instructions].
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals’ Second Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2022 Earnings Call Transcript
Operator: Greetings everyone and welcome to the Marinus Pharmaceuticals' Fourth Quarter and Full-Year 2022 Financial Results and Business Update Call.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings and welcome to the Marinus Pharmaceuticals' Third Quarter 2022 Financial Results and Business Update Call.
Michael Burry Is Dumping These 5 Stocks
Burry had held a stake worth $11 million in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) at the end of the second quarter of 2021.
Michael Burry Stock Portfolio: 10 Newest Additions in 2021
In this article, we discuss the newest stocks in Michael Burry's portfolio.
Billionaire Hedge Funds
